| Medical and Health Sciences | Lifetime | 164 | US 90 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 242 | US 86 | 99.95 |
| Epidemiology | Lifetime | 10 | US 8 | 99.98 |
| Pulmonary and Respiratory Medicine | Lifetime | 163 | US 87 | 99.80 |
| Rehabilitation | Lifetime | 45 | US 21 | 99.44 |
| Clinical Neurology | Lifetime | 156 | US 66 | 99.44 |
| Internal Medicine | Lifetime | 107 | US 38 | 97.69 |
| Neuroscience of Neurology | Lifetime | 528 | US 210 | 95.56 |
| Epidemiology | 2021-2025 | 24 | US 8 | 99.90 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 148 | US 48 | 98.98 |
| Rehabilitation | 2021-2025 | 32 | US 5 | 96.97 |
| Clinical Neurology | 2021-2025 | 144 | US 52 | 96.55 |
| Surgery | 2021-2025 | 910 | US 349 | 91.60 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 538 | US 232 | 92.00 |
| Neuroscience of Neurology | 2021-2025 | 248 | US 87 | 85.20 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 1 | US 1 | 99.97 |
| Acute Ischemic Stroke Management | Lifetime | 1 | US 1 | 99.98 |
| Stroke Rehabilitation and Recovery | Lifetime | 1 | US 1 | 99.97 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 2 | US 1 | 99.93 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 10 | US 4 | 99.91 |
| Cardiovascular and Diving-Related Complications | Lifetime | 10 | US 5 | 99.63 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 15 | US 8 | 99.74 |
| S100 Proteins and Annexins | Lifetime | 32 | US 16 | 99.33 |
| Peripheral Artery Disease Management | Lifetime | 64 | US 45 | 99.30 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 45 | US 20 | 99.47 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 290 | US 139 | 99.13 |
| Intracranial Aneurysms: Treatment and Complications | Lifetime | 197 | US 112 | 98.92 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 211 | US 91 | 98.92 |
| Lipoproteins and Cardiovascular Health | Lifetime | 472 | US 222 | 98.06 |
| Meta-analysis and systematic reviews | Lifetime | 210 | US 57 | 96.83 |
| Cardiovascular Health and Disease Prevention | Lifetime | 769 | US 293 | 96.80 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 478 | US 181 | 96.23 |
| Neurosurgical Procedures and Complications | Lifetime | 447 | US 209 | 96.11 |
| Healthcare Systems and Practices | Lifetime | 625 | US 17 | 92.42 |
| Clinical practice guidelines implementation | Lifetime | 658 | US 170 | 93.98 |
| Moyamoya disease diagnosis and treatment | Lifetime | 624 | US 206 | 90.12 |
| Acute Ischemic Stroke Management | 2021-2025 | 6 | US 3 | 99.89 |
| Stroke Rehabilitation and Recovery | 2021-2025 | 4 | US 2 | 99.85 |
| Cardiovascular and Diving-Related Complications | 2021-2025 | 1 | US 1 | 99.47 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 11 | US 6 | 99.70 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 29 | US 11 | 99.43 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 41 | US 19 | 99.07 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 172 | US 40 | 96.20 |
| Peripheral Artery Disease Management | 2021-2025 | 215 | US 103 | 94.20 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 92 | US 14 | 89.85 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 247 | US 89 | 92.12 |
| Neurosurgical Procedures and Complications | 2021-2025 | 321 | US 141 | 87.20 |
| Intracranial Aneurysms: Treatment and Complications | 2021-2025 | 914 | US 305 | 87.05 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 338 | US 45 | 75.04 |
| Healthcare Systems and Practices | 2021-2025 | 652 | US 24 | 69.20 |
| Moyamoya disease diagnosis and treatment | 2021-2025 | 573 | US 146 | 67.63 |
| S100 Proteins and Annexins | 2021-2025 | 776 | US 167 | 63.46 |
| Neurological Complications and Syndromes | 2021-2025 | 521 | US 125 | 62.39 |
